TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
+2.82%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$1.16B
AUM Growth
+$1.16B
(-2.2%)
Cap. Flow
-$39.6M
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Revolution Medicines
RVMD
|
$39.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Relay Therapeutics
RLAY
$619M
| $439M | 37.66% |
10,551,115
| – | – |
|
|
2
Revolution Medicines
RVMD
$7.1B
| $278M | 23.88% |
7,024,031
-1,000,000
| -12% | -$39.6M |
|
3
Nurix Therapeutics
NRIX
$714M
| $178M | 15.31% |
5,422,549
| – | – |
|
4
Pliant Therapeutics
PLRX
$101M
| $133M | 11.39% |
5,839,160
| – | – |
|
5
Fulcrum Therapeutics
FULC
$351M
| $69.8M | 6% |
5,962,202
| – | – |
|
6
Voyager Therapeutics
VYGR
$186M
| $45.7M | 3.92% |
6,391,176
| – | – |
|
|
JNCE
7
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $21.3M | 1.83% |
3,048,780
| – | – |
|